Nutex Health Inc.
NUTX
$123.54
-$16.97-12.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 213.96% | -42.23% | 91.30% | 90.92% | 89.22% |
| Total Depreciation and Amortization | 7.85% | 13.56% | 15.11% | 20.75% | 33.96% |
| Total Amortization of Deferred Charges | -13.83% | -76.20% | -71.24% | -19.96% | -38.04% |
| Total Other Non-Cash Items | 85.12% | 1,213.60% | -91.09% | -92.94% | -92.45% |
| Change in Net Operating Assets | -6,184.07% | -108.89% | -95.82% | -104.69% | -102.58% |
| Cash from Operations | 1,742.88% | 182.87% | 1,053.05% | -79.55% | -97.52% |
| Capital Expenditure | 75.74% | 55.66% | 38.77% | 43.81% | 35.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 105.36% | -- | -105.54% | -105.54% |
| Divestitures | 65.23% | 65.23% | 31.55% | 100.00% | 57.08% |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.29% | 66.76% | 26.78% | -464.48% | -159.14% |
| Total Debt Issued | -61.67% | 11.56% | -30.47% | 186.89% | 603.72% |
| Total Debt Repaid | 22.64% | 0.50% | -23.22% | -163.59% | -138.71% |
| Issuance of Common Stock | 2,198.17% | 1,587.88% | 1,177.51% | 70.90% | -93.23% |
| Repurchase of Common Stock | -- | -12.84% | -12.84% | -12.84% | -12.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 82.08% | 82.08% | 82.08% | 90.13% | 94.38% |
| Other Financing Activities | -23.46% | 27.78% | 78.22% | 70.10% | 70.14% |
| Cash from Financing | 148.05% | 101.24% | 44.20% | 102.70% | 95.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 276.11% | 305.05% | 154.25% | -3.98% | -557.71% |